Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Molecular imaging of mucosal α4β7 integrin expression with the fluorescent anti-adhesion antibody vedolizumab in Crohn's disease (2017) Rath T, Bojarski C, Neurath M, Atreya R Journal article Precision Medicine in Inflammatory Bowel Diseases (2017) Fischer S, Neurath M Journal article Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders (2017) Zundler S, Neurath M Journal article Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases (2017) Zundler S, Neurath M Journal article Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn's Disease Patients with Active Mucosal Lesions (2017) Suzuki K, Yokoyama J, Kawauchi Y, Honda Y, Sato H, Aoyagi Y, Terai S, et al. Journal article Molecular pathways driving disease-specific alterations of intestinal epithelial cells (2017) Lopez Posadas R, Neurath M, Atreya I Journal article Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice (2017) Popp V, Gerlach K, Mott S, Turowska A, Garn H, Atreya R, Lehr HA, et al. Journal article Microbiota: relevant player in thiopurine metabolisation? (2017) Atreya I, Neurath M Journal article Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis (2017) Reissig S, Tang Y, Nikolaev A, Gerlach K, Wolf C, Davari K, Gallus C, et al. Journal article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article